MiNK Therapeutics, Inc. (INKT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mink Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.616 Good morning and welcome to Mink Therapeutics' fourth quarter and year-end 2025 financial 00:00:04.616 -- 00:00:09.981 results conference call. All participants will be in a listen-only mode until the question-and-answer 00:00:09.981 -- 00:00:12.964 session. As a reminder, this event is being recorded. 00:00:12.964 -- 00:00:16.087 If anyone has any objections, you may disconnect at this time. 00:00:16.087 -- 00:00:20.411 I would now like to turn the conference over to Stephanie Perrin-Nacar, Chief Communications 00:00:20.411 -- 00:00:23.174 Officer. Please go ahead. 00:00:23.174 -- 00:00:26.457 Thank you, Operator, and thank you all for joining us today. 00:00:26.457 -- 00:00:30.822 Today's call is being webcast and will be available on our website for replay. 00:00:30.822 -- 00:00:34.887 I'd like to remind you that this call will include forward-looking statements, including 00:00:34.887 -- 00:00:40.134 those related to our clinical development, regulatory and commercial plans, timelines 00:00:40.134 -- 00:00:43.378 for data releases, and partnership opportunities. 00:00:43.378 -- 00:00:46.922 These statements are subject to risks and uncertainties. 00:00:46.922 -- 00:00:52.128 Please refer to our SEC filings available on our website for a detailed description 00:00:52.128 -- 00:00:57.138 of these risks. Joining me today are Dr. Jennifer Buell, President and 00:00:57.138 -- 00:01:02.463 Chief Executive Officer, Dr. Terese Hammond, Head of Development, and Melissa 00:01:02.463 -- 00:01:06.146 Orell, Principal Financial and Accounting Officer. 00:01:06.146 -- 00:01:10.550 I'd like to turn the call over to Dr. Buell to highlight our progress from this quarter. 00:01:10.550 -- 00:01:12.851 Dr. Buell? 00:01:15.915 -- 00:01:19.979 Thank...